BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8862128)

  • 1. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Yuki N; Tagawa Y; Handa S
    J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.
    Terryberry J; Sutjita M; Shoenfeld Y; Gilburd B; Tanne D; Lorber M; Alosachie I; Barka N; Lin HC; Youinou P
    J Clin Lab Anal; 1995; 9(5):308-19. PubMed ID: 8531012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
    Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
    Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
    Liberatore G; De Lorenzo A; Giannotta C; Manganelli F; Filosto M; Cosentino G; Cocito D; Briani C; Cortese A; Fazio R; Lauria G; Clerici AM; Rosso T; Marfia GA; Antonini G; Cavaletti G; Carpo M; Doneddu PE; Spina E; Cotti Piccinelli S; Peci E; Querol L; Nobile-Orazio E
    Neurol Sci; 2022 Jun; 43(6):3939-3947. PubMed ID: 35048233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.
    Peng J; Zhang H; Liu P; Chen M; Xue B; Wang R; Shou J; Qian J; Zhao Z; Xing Y; Liu H
    Sci Rep; 2018 Feb; 8(1):2824. PubMed ID: 29434217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
    Keddie S; Smyth D; Keh RYS; Chou MKL; Grant D; Surana S; Heslegrave A; Zetterberg H; Wieske L; Michael M; Eftimov F; Bellanti R; Rinaldi S; Hart MS; Petzold A; Lunn MP
    Brain; 2023 Nov; 146(11):4562-4573. PubMed ID: 37435933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ultrasound findings in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy for differential diagnosis.
    Basiri K; Abdollahian M; Ghasemi M
    Curr J Neurol; 2021 Apr; 20(2):56-63. PubMed ID: 38011471
    [No Abstract]   [Full Text] [Related]  

  • 10. A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.
    Remacle AG; Dolkas J; Angert M; Hullugundi SK; Chernov AV; Jones RCW; Shubayev VI; Strongin AY
    J Immunol Methods; 2018 Apr; 455():80-87. PubMed ID: 29428829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies Against Dihydrolipoamide S-Acetyltransferase in Immune-Mediated Neuropathies.
    Fukami Y; Iijima M; Koike HH; Yagi S; Furukawa S; Mouri N; Ouchida J; Murakami A; Iida M; Yokoi S; Hashizume A; Iguchi Y; Imagama S; Katsuno M
    Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200199. PubMed ID: 38181320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
    Horiuchi M; Hongo Y; Yamazaki K; Komuta Y; Kadoya M; Takazaki H; Furuya Y; Matsui T; Sakamoto N; Ikewaki K; Suzuki K; Kaida K
    Intern Med; 2022 Apr; 61(8):1247-1252. PubMed ID: 34615817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials.
    Latov N; Brannagan TH; Sander HW; Gondim FAA
    Arq Neuropsiquiatr; 2024 Jun; 82(6):1-7. PubMed ID: 38325389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Cerebrospinal Fluid Adenosine 5'-Triphosphate Levels in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.
    Nukui T; Niimi H; Hayashi T; Dougu N; Yamamoto M; Shibuya R; Matsuda N; Tanaka R; Hirosawa H; Furuta R; Mitsui T; Maesaka H; Takasawa S; Kitajima I; Nakatsuji Y
    Neurol Res Int; 2024; 2024():7229216. PubMed ID: 38887668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology.
    Caballero-Ávila M; Lleixà C; Pascual-Goñi E; Martín-Aguilar L; Vidal-Fernandez N; Tejada-Illa C; Collet-Vidiella R; Rojas-Garcia R; Cortés-Vicente E; Turon-Sans J; Gallardo E; Olivé M; Vesperinas A; Carbayo Á; Llansó L; Martinez-Martinez L; Shock A; Christodoulou L; Dizier B; Freeth J; Soden J; Dawson S; Querol L
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200216. PubMed ID: 38484217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mimicry between Plasmodium sp and Guillain-Barre syndrome antigens].
    Emiliani-Navarro YM; Vega D; Muzi G; Munera-Gomez M; Sánchez A
    Rev Alerg Mex; 2024 Feb; 71(1):54. PubMed ID: 38683072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.
    Allard DE; Wang Y; Li JJ; Conley B; Xu EW; Sailer D; Kimpston C; Notini R; Smith CJ; Koseoglu E; Starmer J; Zeng XL; Howard JF; Hoke A; Scherer SS; Su MA
    J Clin Invest; 2018 Oct; 128(10):4727-4741. PubMed ID: 30222134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines - impact on clinical practise.
    Allen JA
    Curr Opin Neurol; 2024 Jun; ():. PubMed ID: 38873801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern Perspectives on Peripheral Neuropathology].
    Koike H
    Brain Nerve; 2024 Apr; 76(4):361-374. PubMed ID: 38589281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Demyelinating Diseases: From Biology to Translational Medicine.
    Kamil K; Yazid MD; Idrus RBH; Das S; Kumar J
    Front Neurol; 2019; 10():87. PubMed ID: 30941082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.